IL106263A0 - Derivatives of 16-membered ring antibiotic macrolides - Google Patents

Derivatives of 16-membered ring antibiotic macrolides

Info

Publication number
IL106263A0
IL106263A0 IL106263A IL10626393A IL106263A0 IL 106263 A0 IL106263 A0 IL 106263A0 IL 106263 A IL106263 A IL 106263A IL 10626393 A IL10626393 A IL 10626393A IL 106263 A0 IL106263 A0 IL 106263A0
Authority
IL
Israel
Prior art keywords
derivatives
pct
membered ring
animals
sec
Prior art date
Application number
IL106263A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL106263A0 publication Critical patent/IL106263A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL106263A 1992-07-15 1993-07-07 Derivatives of 16-membered ring antibiotic macrolides IL106263A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91424292A 1992-07-15 1992-07-15
US99624392A 1992-12-23 1992-12-23

Publications (1)

Publication Number Publication Date
IL106263A0 true IL106263A0 (en) 1993-11-15

Family

ID=27129638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106263A IL106263A0 (en) 1992-07-15 1993-07-07 Derivatives of 16-membered ring antibiotic macrolides

Country Status (22)

Country Link
US (1) US5545624A (da)
EP (1) EP0649430B1 (da)
JP (1) JP2836964B2 (da)
KR (1) KR950702570A (da)
CN (1) CN1083068A (da)
AT (1) ATE161265T1 (da)
AU (1) AU4401093A (da)
BR (1) BR9306741A (da)
CA (1) CA2140243A1 (da)
CZ (1) CZ9995A3 (da)
DE (1) DE69315839T2 (da)
DK (1) DK0649430T3 (da)
FI (1) FI933204A (da)
GR (1) GR3026064T3 (da)
HU (1) HUT65330A (da)
IL (1) IL106263A0 (da)
MX (1) MX9304301A (da)
PL (1) PL307137A1 (da)
SK (1) SK4795A3 (da)
TW (1) TW226373B (da)
UY (1) UY23617A1 (da)
WO (1) WO1994002496A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677287A (en) * 1993-03-18 1997-10-14 Pfizer Inc. Antibacterial 16-membered ring macrolides containing olefins at C-20
DE69402714T2 (de) * 1993-07-15 1997-07-31 Pfizer Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
ES2076107B1 (es) * 1993-09-20 1996-04-01 Pfizer Derivados de antibioticos macrolidos de anillos de 16 miembros.
WO1996009312A1 (en) * 1994-09-22 1996-03-28 Pfizer Inc. Antibiotic macrolides
EP0778283A3 (en) * 1995-12-05 1998-01-28 Pfizer Inc. Antibiotic macrolides
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
ATE261450T1 (de) * 1999-08-30 2004-03-15 Zaidan Hojin Biseibutsu Makrolid-antibiotika und behandlung von pasteurellosis
US20020128213A1 (en) * 2000-09-25 2002-09-12 Leonard Katz Sixteen-membered macrolide compounds
US6664240B2 (en) * 2001-11-15 2003-12-16 Enanta Pharmaceuticals, Inc. Tylosin derivatives having antibacterial activity
DE60330651D1 (en) 2002-03-12 2010-02-04 Bristol Myers Squibb Co C3-cyanoepothilonderivate
US7247617B2 (en) * 2004-07-13 2007-07-24 Kosan Biosciences Incorporated Sixteen-member macrolide antiinfective agents
WO2008012343A2 (en) 2006-07-28 2008-01-31 Intervet International B.V. Macrolide synthesis process
UA98303C2 (ru) * 2006-07-28 2012-05-10 Интервет Интернешонал Б.В. Способ синтеза макролидов
SI2782922T1 (en) 2011-11-25 2018-05-31 Bayer Intellectual Property Gmbh ANTIBACTERIAL TYLOSINE DERIVATIVES AND PREPARATION PROCEDURES
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
MY184630A (en) * 2013-05-23 2021-04-11 Bayer Animal Health Gmbh Tylosin derivatives and method for preparation thereof
CN104788519B (zh) * 2014-01-22 2018-07-20 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN105777828A (zh) * 2014-12-22 2016-07-20 菏泽市方明制药有限公司 一种用低质量的泰乐菌素制备高质量替米考星的方法
US10287275B2 (en) 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN117510561B (zh) * 2023-11-30 2024-04-02 中国农业科学院饲料研究所 一种泰乐菌素衍生物及其制备方法与应用
CN117304241B (zh) * 2023-11-30 2024-03-01 中国农业科学院饲料研究所 一种大环内酯类化合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975372A (en) * 1975-02-28 1976-08-17 Schering Corporation Preparation of 12,13-desepoxy-12,13-dehydrorosamicin
IL69666A (en) * 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found 20,23−ジデオキシ−23−アルキレンイミノ−20−置換アミノマイカミノシルレロノライド
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found 20,23−ジデオキシ−20,23−ビス置換アミノ−マイカミノシルレロノライド
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) * 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
EP0262903A3 (en) * 1986-09-29 1988-11-02 Eli Lilly And Company New acyl derivatives of 20-modified tylosin and desmycosin compounds
US4820694A (en) * 1986-09-29 1989-04-11 Eli Lilly And Company Modifications of 3-O-demethylmycinose in macrocin and lactenocin
FR2638458A1 (fr) * 1988-10-27 1990-05-04 Adir Nouveaux derives de la tylosine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CZ9995A3 (en) 1995-07-12
DE69315839T2 (de) 1998-04-09
AU4401093A (en) 1994-02-14
CN1083068A (zh) 1994-03-02
MX9304301A (es) 1994-02-28
TW226373B (da) 1994-07-11
BR9306741A (pt) 1998-12-08
DE69315839D1 (de) 1998-01-29
HUT65330A (en) 1994-05-02
UY23617A1 (es) 1994-01-05
US5545624A (en) 1996-08-13
ATE161265T1 (de) 1998-01-15
GR3026064T3 (en) 1998-05-29
JP2836964B2 (ja) 1998-12-14
WO1994002496A1 (en) 1994-02-03
PL307137A1 (en) 1995-05-02
FI933204A (fi) 1994-01-16
JPH07504922A (ja) 1995-06-01
HU9302016D0 (en) 1993-10-28
SK4795A3 (en) 1995-07-11
DK0649430T3 (da) 1998-02-09
FI933204A0 (fi) 1993-07-14
EP0649430B1 (en) 1997-12-17
CA2140243A1 (en) 1994-02-03
EP0649430A1 (en) 1995-04-26
KR950702570A (ko) 1995-07-29

Similar Documents

Publication Publication Date Title
GR3026064T3 (en) Derivatives of 16-membered ring antibiotic macrolides.
IL110240A0 (en) Amide derivatives of 16-membered ring antibiotic macrolides
NZ335825A (en) Use of azithromycin for treating atherosclerosis
NZ514917A (en) Ketolide antibacterials
IL136088A0 (en) 6-0-alkyl erythromycin b oxime
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
HUP0004579A2 (hu) Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények
NZ513206A (en) 6-O-substituted macrolides having antibacterial activity
SI0808326T1 (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
MX9606111A (es) Antibioticos macrolidos.
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
HU9904393D0 (en) Medicament for defence of retching of dogs containing azithromycin
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
NO950143L (no) Derivater av antibiotiske makrolider med 16-leddet ring
MX9803694A (es) Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.
IL83626A (en) Macrolide antibiotic, swalpamycin, a microbiological process for its preparation and pharmaceutical compositions containing same
CA2471102A1 (en) Crystal form ii of clarithromycin
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.